Neuracle Genetics
Developer of an adeno-associated virus gene therapy designed to improve the quality of life of patients. The company utilizes AAV gene therapy applications for treating neurodegenerative disorders and...
Valuation
$0
Share Price
N/A
Total Raised
$81.4M
Last Round
N/A